Khandelwal Kanika, Madathala Rajasekhar R, Chennaiahgari Nikhita, Yousuffuddin Mohammed
Internal Medicine, Mayo Clinic Health System, Austin, USA.
Hepatology and Transplant, Mayo Clinic, Rochester, USA.
Cureus. 2021 May 16;13(5):e15065. doi: 10.7759/cureus.15065.
Steroids are one of the most commonly used drugs and known to be associated with several side effects. There have been case reports about the associated sinus bradycardia with pulse dose corticosteroids administration both IV and oral. We present a case of asymptomatic sinus bradycardia associated with oral prednisone 40 mg. A 69-year-old male was admitted to the ICU for sepsis and subsequently was found to have gastrointestinal (GI) bleed. He developed an acute gout attack during hospitalization and was treated with prednisone 40 mg. Over the next 24 hours, the patient's heart rate dropped to 30s to 40s beats/minute while other vitals have remained stable. He was monitored on telemetry and review of the rhythm strips, as well as a 12-lead electrocardiogram (EKG), that showed sinus bradycardia; no pauses or atrio-ventricular (AV) nodal blocks were identified. The patient was not on any beta blocker or other therapies commonly associated with sinus bradycardia. His steroids were stopped while all other medications were continued. His heart rate slowly started to improve over the next 24 hours. He was not found to have any further episodes of bradycardia. Our case is unusual as we noted transient asymptomatic bradycardia with oral prednisone 40 mg dose. While bradycardia is reversible and may go unnoticed, it is important for the clinician to be aware of this adverse effect and include it in the list of potential differentials for bradycardia.
类固醇是最常用的药物之一,已知会产生多种副作用。有病例报告称,静脉注射和口服脉冲剂量皮质类固醇会导致窦性心动过缓。我们报告一例与口服40毫克泼尼松相关的无症状窦性心动过缓病例。一名69岁男性因脓毒症入住重症监护病房,随后被发现有胃肠道出血。他在住院期间发生急性痛风发作,接受了40毫克泼尼松治疗。在接下来的24小时内,患者心率降至每分钟30至40次,而其他生命体征保持稳定。通过遥测对其进行监测,并查看心律条图以及12导联心电图(EKG),结果显示为窦性心动过缓;未发现停顿或房室(AV)结阻滞。患者未服用任何β受体阻滞剂或其他通常与窦性心动过缓相关的疗法。停用了他的类固醇药物,同时继续使用所有其他药物。在接下来的24小时内,他的心率开始缓慢改善。未发现他有进一步的心动过缓发作。我们的病例不同寻常,因为我们注意到口服40毫克泼尼松剂量会导致短暂的无症状心动过缓。虽然心动过缓是可逆的,可能未被注意到,但临床医生意识到这种不良反应并将其列入心动过缓潜在鉴别诊断列表中很重要。